Rossella Rota

21PUBLICATIONS

92CO-AUTHORS

Molecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)BiomechanicsRadiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|Jun 01, 2026

Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivo.

|Mar 28, 2026

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Katie E Hebron, Patience Odeniyide, Yun Wei

|Nov 03, 2025

Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcoma.

Francesca Antonella Aiello, Lucrezia D'Archivio, Marika Attili

|Aug 14, 2025

The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes.

Silvia Pomella, Lucrezia D'Archivio, Matteo Cassandri

|Aug 04, 2025

Heat Shock Proteins: Important Helpers for the Development, Maintenance and Regeneration of Skeletal Muscles.

Silvia Pomella, Matteo Cassandri, Francesco Antoniani

|Aug 06, 2024

HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks.

Matteo Cassandri, Antonella Porrazzo, Silvia Pomella

Pageof 4

Frequent Collaborators

11 joint publications

Silvia Pomella

Matteo Cassandri

Berkley E Gryder

Franco Locatelli

Simona Camero

Francesca Megiorni

Javed Khan

Giovanni Barillari

Benjamin Z Stanton

Cinzia Marchese

Frequent Collaborators

11 joint publications

Silvia Pomella

8 joint publications

Matteo Cassandri

5 joint publications

Berkley E Gryder

5 joint publications

Franco Locatelli